Clinical Trial Update: Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating phenelzine sulfate in non-metastatic recurrent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Phenelzine sulfate (Phenelzine sulfate)

Snippet

Sponsor: University of Southern California | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED